4.0 Review

Preoperative Medical Treatment for Patients With Acromegaly: Yes or No

Journal

JOURNAL OF THE ENDOCRINE SOCIETY
Volume 6, Issue 9, Pages -

Publisher

ENDOCRINE SOC
DOI: 10.1210/jendso/bvac114

Keywords

acromegaly; somatostatin analogs; surgery; cabergoline; anesthesia; growth-hormone; IGF-1

Ask authors/readers for more resources

Transsphenoidal surgery is the primary treatment for acromegaly, but surgical remission rates can be affected by various factors. The benefits of presurgical medical treatment using somatostatin receptor ligands (SRLs) are still unclear, but it may improve patient condition and decrease surgical complications by normalizing hormone levels and reducing tumor size.
Transsphenoidal surgery is the first-line treatment for acromegaly. However, several factors can modify surgical remission rates, such as the initial hormone levels, the size and invasiveness of the tumor, and the degree of experience of the surgeon. Physicians treating patients with acromegaly should thus consider how to improve surgical remission rates. As stated in recent guidelines, the major point is to consider that any patient with acromegaly should be referred to an expert neurosurgeon to maximize the chances of surgical sure. The benefits of presurgical medical treatment, mainly using somatostatin receptor ligands (SRLs), given 3 to 6 months before surgery, remain controversial. By normalizing growth hormone and insulin-like growth factor 1 levels, SRLs may improve the overall condition of the patient, thus decreasing anesthetic and surgical complications. By decreasing the tumor size and modifying the consistency of the tumor, SRLs might also make surgical excision easier. This is however theoretical as published data are contradictory on both points, and only limited data support the use of a systematical presurgical medical treatment. The aim of this review is to analyze the potential benefits and pitfalls of using presurgical medical treatment in acromegaly in view of the contradictory literature data. We also attempt to determine the profile of patients who might most benefit from this presurgical medical treatment approach as an individualized therapeutic management of acromegaly.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available